Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The US Surgeon General's advisory on cancer and alcohol sent shares of beverage makers lower, but its effects may be much ...

The Anheuser-Busch InBev S.A. ADR shed 0.28% to $49.93 Thursday, on what proved to be an all-around rough trading session for ...

BUD stock continues its downtrend due to ongoing cost headwinds. However, its focus on premiumization and the Beyond Beer ...

U.S. stocks were higher on Friday, but shares of alcoholic beverage makers were lower after the surgeon general announced a ...

Popular alcohol producers had a bumpy morning as investors reacted to an advisory from the U.S. Surgeon General about alcohol and cancer.

Russian President Vladimir Putin has given a local company control of Anheuser-Busch InBev’s joint venture, upending the ...

Shares in beer, wine and spirits companies such as Anheuser-Busch InBev, Boston Beer and Constellation Brands fell after the ...

Friday’s warning from the US surgeon general that alcohol is a “well-established, preventable cause of cancer” is perhaps a ...

Scientific evidence of the connections between alcohol and cancer has been rising for decades, the Surgeon General warned.

The Anheuser-Busch InBev S.A. ADR shed 1.17% to $49.78 Monday, on what proved to be an all-around dismal trading session for ...